Hygeia

F-star to be acquired by China biopharmaceutical with USD 161million

"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange

Herui gene launched the early screening product "quansining" for multiple cancer types, covering six high-risk cancer types

East China medicine "liraglutide" goes to sea

Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care

Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing

Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China

Yanye new crown drug 3CL protein inhibitor has been suspended approval

Sanofi Greater China will be headed by Shi Wang, and Henting he will become the global head of the digital business unit

Acadia Alzheimer's drug SNDA application rejected by FDA advisory committee

Huashen Zhiyao completed nearly 500million yuan of a-round financing and went deep into AI new drug development

Huamei Haolian, a health management service enterprise, completed round a+ financing, and Jinshajiang venture capital led the investment

Mojia biology announced the completion of round B financing

First class recall of Draeger, a ventilator giant

Hong Kong Pharmaceutical stocks plunged straight in the afternoon